Selective Nonpeptidic Fluorescent Ligands for Oxytocin Receptor: Design, Synthesis, and Application to Time-Resolved FRET Binding Assay

Journal of Medicinal Chemistry
2015.0

Abstract

The design and the synthesis of the first high-affinity fluorescent ligands for oxytocin receptor (OTR) are described. These compounds enabled the development of a TR-FRET based assay for OTR, readily amenable to high throughput screening. The validation of the assay was achieved by competition experiments with both peptide and nonpeptide OTR ligands as competitors. These probes represent the first selective fluorescent ligands for the oxytocin G protein-coupled receptor.

Knowledge Graph

Similar Paper

Selective Nonpeptidic Fluorescent Ligands for Oxytocin Receptor: Design, Synthesis, and Application to Time-Resolved FRET Binding Assay
Journal of Medicinal Chemistry 2015.0
Synthesis and Characterization of Fluorescent Antagonists and Agonists for Human Oxytocin and Vasopressin V<sub>1</sub><sub>a</sub>Receptors
Journal of Medicinal Chemistry 2002.0
Design, Synthesis, and Pharmacological Characterization of Fluorescent Peptides for Imaging Human V1b Vasopressin or Oxytocin Receptors
Journal of Medicinal Chemistry 2011.0
Synthesis, Biological Evaluation, and Utility of Fluorescent Ligands Targeting the μ-Opioid Receptor
Journal of Medicinal Chemistry 2015.0
Development of time resolved fluorescence resonance energy transfer-based assay for FXR antagonist discovery
Bioorganic &amp; Medicinal Chemistry 2013.0
Fluorescent-Labeled Selective Adenosine A<sub>2B</sub>Receptor Antagonist Enables Competition Binding Assay by Flow Cytometry
Journal of Medicinal Chemistry 2018.0
LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism
Journal of Medicinal Chemistry 2018.0
Development and Characterization of Fluorescent Probes for the G Protein-Coupled Receptor 35
ACS Medicinal Chemistry Letters 2023.0
Flexible analogues of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin 1 a receptors
European Journal of Medicinal Chemistry 2016.0
Discovery and optimization of highly ligand-efficient oxytocin receptor antagonists using structure-based drug design
Bioorganic &amp; Medicinal Chemistry Letters 2009.0